Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
AIM 01 May 2024 NOTICE 01/05/2024 - 07:00 NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM At the request of the company the following securities have been cancelled from trading...
Redx Pharma plc 30 April 2024 REDX PHARMA PLC ("Redx" or the "Company") Share Purchases by a PDMR Alderley Park, UK, 30 April 2024 Redx (AIM:REDX), the clinical-stage biotechnology company...
Redx Pharma plc 30 April 2024 REDX PHARMA PLC ("Redx" or the "Company") Share Purchases by PDMR's Alderley Park, UK, 30 April 2024 Redx (AIM:REDX), the clinical-stage biotechnology...
Redx Pharma plc 29 April 2024 REDX PHARMA PLC ("Redx" or the "Company") Update on AIM Delisting Alderley Park, UK, 29 April 2024 Redx (AIM:REDX), the clinical-stage biotechnology...
Redx Pharma plc 22 April 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...
clinical-stage biotechnology company - Shareholders pass resolution by 99.75% margin at general meeting to approve ca ...
Redx Pharma plc 19 April 2024 REDX PHARMA PLC ("Redx" or the "Company") Result of General Meeting and Cancellation of Admission to Trading on AIM Alderley Park, UK, 19 April 2024 Redx...
Redx Pharma plc 18 April 2024 REDX PHARMA PLC ("Redx" or the "Company") Share Purchases by a Director Alderley Park, UK, 18 April 2024 Redx (AIM:REDX), the clinical-stage biotechnology...
Redx Pharma plc 12 April 2024 REDX PHARMA PLC ("Redx" or the "Company") Share Purchase by a Director Alderley Park, UK, 12 April 2024 Redx (AIM:REDX), the clinical-stage biotechnology...
Redx Pharma plc 10 April 2024 REDX PHARMA PLC ("Redx" or the "Company") Update on Broking Arrangements Alderley Park, UK, 10 April 2024 Redx (AIM:REDX), the clinical-stage biotechnology...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
